Adenine monophosphate‐activated protein kinase (AMPK), a well-known cellular energy sensor, functions as an essential component in the maintenance of energy homeostasis in normal cells and has been established as a major contributor (and hence therapeutic target) to both metabolic syndromes and cancers[1]. This evidence concerns the gene PRKAB1 and cancer.